The Global Resource For Connecting Buyers and Sellers

Betalutin® Shows Strong Clinical Profile in Relapsed/refractory Indolent NHL and Follicular Lymphoma

OSLO, Norway, Dec. 11, 2017 /PRNewswire/ —
Nordic Nanovector ASA (OSE: NANO) has presented updated results from its LYMRIT 37-01 Phase 1/2 clinical study of Betalutin® (177Lu-satetraxetan-lilotomab) in patients with relapsed/refractory (R/R) indolent NHL (iNHL) at the 59th Annual ASH…